Please login to the form below

Not currently logged in

Yasuchika Hasegawa

This page shows the latest Yasuchika Hasegawa news and features for those working in and with pharma, biotech and healthcare.

Takeda CEO admits to Blopress mis-marketing

Takeda CEO admits to Blopress mis-marketing

Campaign used graph indicating drug was superior to Pfizer’s Norvasc. Takeda's chief executive Yasuchika Hasegawa has admitted the company may have used "inappropriate" language in its marketing of blood ... The mis-marketing stemmed from a trial

Latest news

  • Takeda appoints GSK's Weber as chief operating officer Takeda appoints GSK's Weber as chief operating officer

    Current president and CEO Yasuchika Hasegawa is expected to be named chairman and interim CEO at Takeda in June, but could hand over the reins within the following few months if ... 67-year-old Hasegawa started the search for a new CEO last year.

  • Takeda buys Nycomed and names CEO

    Yasuchika Hasegawa, president and CEO of Takeda, said: "Partnering the two organisations will have complementary effects and further increase our potential to become a truly global pharmaceutical company.".

  • IBS drug approved in the US

    Yasuchika Hasegawa, president of Takeda, said: "This additional indication for Amitiza will help Takeda further enhance our position in the US primary care and GI speciality markets.".

  • Lundbeck and Takeda form US and Japan CNS alliance

    Other financial details were undisclosed. Yasuchika Hasegawa, president and CEO of Takeda, said: "We are delighted to have reached an agreement with one of the strongest global players in central nervous

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Takeda appoints Christophe Weber as its new CEO Takeda appoints Christophe Weber as its new CEO

    firm. This will become effective from April 1 this year. He will take over from the long-standing Yasuchika Hasegawa, who will become the new chairman of the board. ... Weber, formerly of GlaxoSmithKline, said: “First, I would like to thank Yasuchika

  • Takeda appoints new financial head Takeda appoints new financial head

    He will lead the integration and leadership of the finance functions across Takeda and will report to the company's president and CEO Yasuchika Hasegawa. ... senior leadership team at Takeda,” said Hasegawa.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...